Search
Recommended Sites
Related Links






   

Informative Articles

Accutane without the ouch
Since 1982 Accutane has been a reliable, if not controversial, drug for treating severe acne. Now with FDA representative David J. Graham's statement that Accutane should be taken off the market, and pharmaceutical manufacturer La Roche's defense of...

Acne Laser Treatments - How They Help With Scarring and Formation of Acne
Acne Laser Treatment - How You Can Now "Do It Yourself" at Home for a Fraction of the Price, and Get the Same Results There are always new ways to treat acne coming out as the latest and greatest method to treat acne and smooth the skin out...

Acne Medications
Acne is an annoying skin condition that affects people of every age, gender, and race. Few skin conditions are as bothersome and disturbing as acne. The scientific name for the condition is acne vulgaris because acne usually strikes in plainly...

Acne Products
Few skin conditions are as bothersome and disturbing as acne. It is a skin condition that usually begins around the time of puberty. But it can affect people of every age, gender, and race. The scientific name for the condition is acne vulgaris...

Oral Acne Medication Options
At the onslaught of puberty, many teens suffer from various radical changes - physical, physiological, emotional.. you name it! Of course, one of the most apparent transformations is that of the physical changes. Aside from the males developing more...

 
Acne: Asthma Drug Fails to Help Patients with Acne

The asthma drug Zyflo fails to help patients with severe acne, according to a mid-stage trial carried out by the company Critical Therapeutics Inc. The drug, also known as zileuton, was neither better at controlling the number of inflammatory lesions than placebos under the company statistics.

Over the 12-week trial, patients treated with Zyflo had an average reduction of 11.5 inflammatory lesions. That compared with a reduction of 9.1 lesions in a group of other patients taking placebos - far short of achieving statistical significance.

Patients treated with placebo showed a reduction of 16.4 lesions in the placebo group, but patients treated with Zyflo showed a mean reduction in the total number of lesions of 25.3.

The company stated the medicine showed a trend of potential benefit to some patients although the drug failed the primary goal of the trial.

Linda Lennox, the company spokeswoman, told the company will probably conduct a larger trial testing the medicine as an acne treatment, using information gleaned from the small recent "proof of concept" trial.

The company based in Lexington, Massachusetts, said that it is continuing to analyze the data and is working with the investigators to further interpret the results.

Zyflo blocks an inflammation-causing enzyme called 5 lipoxygenase (5-LO). It was approved by U.S. regulators in 1996 for treating asthma patients 12 years of age and older. At the time, the drug was owned by Abbott Laboratories Inc., which sold it for a number of years before licensing it to Critical Therapeutics in late 2003.

Article written by Hector Milla, editor of http://www.acnetreatment stips.com , a website pointing acne treatment tips and http://www.acnesoluti onsproducts.com , visit for reviews and acne solution products information . Thanks for use this article in your website or ezine keeping a live link.

About the author:

Article written by Hector Milla, editor of http://www.acnetreatment stips.com , a website pointing acne treatment tips and http://www.acnesoluti onsproducts.com , visit for reviews and acne solution pr

Sign up for PayPal and start accepting credit card payments instantly.